Catalina Capital Group, LLC Liquidia Corp Transaction History
Catalina Capital Group, LLC
- $299 Billion
- Q3 2024
A detailed history of Catalina Capital Group, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Catalina Capital Group, LLC holds 17,182 shares of LQDA stock, worth $182,988. This represents 0.06% of its overall portfolio holdings.
Number of Shares
17,182
Previous 20,621
16.68%
Holding current value
$182,988
Previous $247 Million
30.56%
% of portfolio
0.06%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding LQDA
# of Institutions
171Shares Held
44.3MCall Options Held
1.55MPut Options Held
1.52M-
Patient Square Capital LP Menlo Park, CA7.18MShares$76.5 Million26.66% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$45.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$36.7 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$35 Million0.17% of portfolio
-
Findell Capital Management LLC New York, NY3.19MShares$34 Million16.08% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $685M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...